Avricore Health Inc. (FRA:8VP1)
Germany flag Germany · Delayed Price · Currency is EUR
0.0470
0.00 (0.00%)
At close: Jan 23, 2026

Avricore Health Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-1.63-0.67-0.7-0.82-1.71-1.17
Depreciation & Amortization
0.230.440.410.180.02-
Other Amortization
0.020.010.01---
Loss (Gain) From Sale of Assets
0.030.03----
Asset Writedown & Restructuring Costs
0.770.77----
Stock-Based Compensation
0.420.540.70.330.50.13
Provision & Write-off of Bad Debts
--00.01--
Other Operating Activities
--0.01--0.040.29
Change in Accounts Receivable
0.560.010.34-0.69-0.080
Change in Inventory
-00.02-0.02---0.18
Change in Accounts Payable
-0.5-0.160.180.27-0.07-0.34
Change in Unearned Revenue
---0.250.25--
Change in Other Net Operating Assets
-0.040.02-0.010.020.070.05
Operating Cash Flow
-0.1510.66-0.44-1.23-1.22
Operating Cash Flow Growth
-52.12%----
Capital Expenditures
-0.09-0.18-1.02-1.19-0.11-
Sale (Purchase) of Intangibles
-0.03-0.02-0.03-0.01-0.04-
Investment in Securities
----0.01--
Investing Cash Flow
-0.12-0.21-1.05-1.21-0.14-
Short-Term Debt Issued
-----0.94
Total Debt Issued
-----0.94
Short-Term Debt Repaid
--0.03---1-
Long-Term Debt Repaid
------0.01
Total Debt Repaid
--0.03---1-0.01
Net Debt Issued (Repaid)
--0.03---10.93
Issuance of Common Stock
0.020.090.040.254.180.64
Other Financing Activities
-----0.1-0.06
Financing Cash Flow
0.020.060.040.253.081.51
Foreign Exchange Rate Adjustments
-0-0----
Net Cash Flow
-0.250.86-0.34-1.391.710.29
Free Cash Flow
-0.240.82-0.36-1.63-1.34-1.22
Free Cash Flow Margin
-12.30%17.21%-10.36%-92.24%-1090.74%-3703.89%
Free Cash Flow Per Share
-0.000.01-0.00-0.02-0.01-0.02
Levered Free Cash Flow
0.050.79-0.05-1.23-0.65-1.06
Unlevered Free Cash Flow
0.050.79-0.05-1.23-0.63-0.97
Change in Working Capital
0.01-0.110.23-0.14-0.08-0.47
Source: S&P Global Market Intelligence. Standard template. Financial Sources.